Roche earnings edge up 5% as forex effects weigh on drug sales growth
Forex effects damp Roche’s drug sales growthCEO Schinecker’s tenure has seen drug trial winsRoche invests in obesity drugs…
Swiss Re’s Record Profit Fails to Impress Shareholders
Swiss Re announces major capital return after record 2025 profit, but shares lag due to cautious 2026 outlook.…